Syntegon acquires Telstar
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
HaystackAnalytics is engaged in the business of developing genomic analysis software
PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
The collaboration aims to bolster healthcare entrepreneurship
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
Subscribe To Our Newsletter & Stay Updated